{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:30:18Z","timestamp":1793410218956,"version":"4.5.0"},"reference-count":235,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013161","name":"Swiss Life Stiftung f\u00fcr Chancenreichtum und Zukunft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013161","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004362","name":"Schweizerische Herzstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004362","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008477","name":"Heubergstiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008477","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010109","name":"Medizinische Universit\u00e4t Graz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010109","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008273","name":"Novartis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008273","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["PR00P3_179861\/1"],"award-info":[{"award-number":["PR00P3_179861\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.phrs.2026.108320","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T23:25:27Z","timestamp":1782343527000},"page":"108320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Bile acids: New regulators of the cardiometabolic crosstalk"],"prefix":"10.1016","volume":"230","author":[{"given":"Stefan","family":"Wolf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa","family":"Nagler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8196-5696","authenticated-orcid":false,"given":"Elena","family":"Osto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.molmed.2024.02.007","article-title":"Eating disorders and obesity: bridging clinical, neurobiological, and therapeutic perspectives","volume":"30","author":"Camacho-Barcia","year":"2024","journal-title":"Trends Mol. Med."},{"issue":"10481","key":"10.1016\/j.phrs.2026.108320_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990-2021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","year":"2025","journal-title":"Lancet"},{"issue":"23","key":"10.1016\/j.phrs.2026.108320_bib3","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/CIR.0b013e318267e99f","article-title":"Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke)","volume":"126","author":"Smith","year":"2012","journal-title":"Circulation"},{"issue":"38","key":"10.1016\/j.phrs.2026.108320_bib4","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1093\/eurheartj\/ehae508","article-title":"Obesity and cardiovascular disease: an ESC clinical consensus statement","volume":"45","author":"Koskinas","year":"2024","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib5","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2400229","article-title":"Associations between Class I, II, or III Obesity and Health Outcomes","volume":"4","author":"Yao","year":"2025","journal-title":"NEJM Evid."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib6","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jama.2017.20897","article-title":"Effect of laparoscopic sleeve gastrectomy vs laparoscopic roux-en-Y gastric bypass on weight loss in patients with morbid obesity: The SM-BOSS randomized clinical trial","volume":"319","author":"Peterli","year":"2018","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib7","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/s41591-025-04124-5","article-title":"The expanding landscape of GLP-1 medicines","volume":"32","author":"Drucker","year":"2026","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.phrs.2026.108320_bib9","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat. Rev. Cardiol."},{"issue":"8","key":"10.1016\/j.phrs.2026.108320_bib10","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41573-025-01183-8","article-title":"GLP-1-based therapies for diabetes, obesity and beyond","volume":"24","author":"Drucker","year":"2025","journal-title":"Nat. Rev. Drug. Discov."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/nu13041104","article-title":"Role of Bile Acids in the Regulation of Food Intake, and Their Dysregulation in Metabolic Disease","volume":"13","author":"Xie","year":"2021","journal-title":"Nutrients"},{"issue":"14","key":"10.1016\/j.phrs.2026.108320_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/cells12141888","article-title":"Bile acids, intestinal barrier dysfunction, and related diseases","volume":"12","author":"Shi","year":"2023","journal-title":"Cells"},{"issue":"7075","key":"10.1016\/j.phrs.2026.108320_bib13","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"},{"issue":"1-2","key":"10.1016\/j.phrs.2026.108320_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ejphar.2005.05.037","article-title":"Deoxycholyltaurine-induced vasodilation of rodent aorta is nitric oxide- and muscarinic M(3) receptor-dependent","volume":"517","author":"Khurana","year":"2005","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib15","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1752-8062.2011.00272.x","article-title":"Bile acids regulate cardiovascular function","volume":"4","author":"Khurana","year":"2011","journal-title":"Clin. Transl. Sci."},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib16","doi-asserted-by":"crossref","first-page":"H272","DOI":"10.1152\/ajpheart.01075.2008","article-title":"Antiatherosclerotic effect of farnesoid X receptor","volume":"296","author":"Mencarelli","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib17","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol. Rev."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11010004","article-title":"Modulation of Bile Acid Metabolism to Improve Plasma Lipid and Lipoprotein Profiles","volume":"11","author":"Zhang","year":"2021","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib19","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jhep.2003.11.006","article-title":"Regulation of bile acid synthesis: pathways, nuclear receptors, and mechanisms","volume":"40","author":"Chiang","year":"2004","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib20","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/s42255-022-00559-z","article-title":"Metabolic messengers: bile acids","volume":"4","author":"Perino","year":"2022","journal-title":"Nat. Metab."},{"key":"10.1016\/j.phrs.2026.108320_bib21","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3389\/fphar.2018.00939","article-title":"Bile acid synthesis: from nature to the chemical modification and synthesis and their applications as drugs and nutrients","volume":"9","author":"Sarenac","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108320_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1146\/annurev.biochem.72.121801.161712","article-title":"The enzymes, regulation, and genetics of bile acid synthesis","volume":"72","author":"Russell","year":"2003","journal-title":"Annu. Rev. Biochem."},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib23","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/hep.23721","article-title":"Transgenic expression of cholesterol 7alpha-hydroxylase in the liver prevents high-fat diet-induced obesity and insulin resistance in mice","volume":"52","author":"Li","year":"2010","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.phrs.2026.108320_bib24","doi-asserted-by":"crossref","DOI":"10.3390\/biom14070841","article-title":"Bile acids as emerging players at the intersection of steatotic liver disease and cardiovascular diseases","volume":"14","author":"Bilson","year":"2024","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib25","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1152\/physrev.00049.2019","article-title":"Molecular physiology of bile acid signaling in health, disease, and aging","volume":"101","author":"Perino","year":"2021","journal-title":"Physiol. Rev."},{"issue":"2(2","key":"10.1016\/j.phrs.2026.108320_bib26","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.2337\/dc09-S355","article-title":"Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration","volume":"32","author":"Staels","year":"2009","journal-title":"Diabetes Care"},{"issue":"8","key":"10.1016\/j.phrs.2026.108320_bib27","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nrendo.2014.60","article-title":"Beyond intestinal soap--bile acids in metabolic control","volume":"10","author":"Kuipers","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib28","doi-asserted-by":"crossref","first-page":"308","DOI":"10.12998\/wjcc.v9.i2.308","article-title":"Overview of bile acid signaling in the cardiovascular system","volume":"9","author":"Zhang","year":"2021","journal-title":"World J. Clin. Cases"},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00281-022-00935-7","article-title":"Bile acids and their receptors: modulators and therapeutic targets in liver inflammation","volume":"44","author":"Bertolini","year":"2022","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.phrs.2026.108320_bib30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/164_2019_236","article-title":"Bile acid-activated receptors: a review on fxr and other nuclear receptors","volume":"256","author":"Shin","year":"2019","journal-title":"Handb. Exp. Pharmacol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108320_bib31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/0092-8674(95)90530-8","article-title":"Identification of a nuclear receptor that is activated by farnesol metabolites","volume":"81","author":"Forman","year":"1995","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib32","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/s41392-024-01811-6","article-title":"Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets","volume":"9","author":"Fleishman","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib33","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/BJ20060537","article-title":"Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation","volume":"398","author":"Vassileva","year":"2006","journal-title":"Biochem. J."},{"issue":"7","key":"10.1016\/j.phrs.2026.108320_bib34","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1161\/ATVBAHA.113.301565","article-title":"Bile acid receptor TGR5 agonism induces NO production and reduces monocyte adhesion in vascular endothelial cells","volume":"33","author":"Kida","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108320_bib35","article-title":"TGR5 Expression Is Associated with Changes in the Heart and Urinary Bladder of Rats with Metabolic Syndrome","volume":"11","author":"Hsu","year":"2021","journal-title":"Life (Basel)"},{"issue":"11","key":"10.1016\/j.phrs.2026.108320_bib36","doi-asserted-by":"crossref","first-page":"9435","DOI":"10.1074\/jbc.M209706200","article-title":"A G protein-coupled receptor responsive to bile acids","volume":"278","author":"Kawamata","year":"2003","journal-title":"J. Biol. Chem."},{"issue":"6","key":"10.1016\/j.phrs.2026.108320_bib37","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2010.12.004","article-title":"The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation","volume":"54","author":"Pols","year":"2011","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108320_bib38","doi-asserted-by":"crossref","first-page":"3961","DOI":"10.1210\/en.2015-1321","article-title":"Bile Acids Trigger GLP-1 Release Predominantly by Accessing Basolaterally Located G Protein-Coupled Bile Acid Receptors","volume":"156","author":"Brighton","year":"2015","journal-title":"Endocrinology"},{"issue":"7","key":"10.1016\/j.phrs.2026.108320_bib39","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/j.cmet.2021.04.009","article-title":"Hypothalamic bile acid-TGR5 signaling protects from obesity","volume":"33","author":"Castellanos-Jankiewicz","year":"2021","journal-title":"Cell. Metab."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib40","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.bbrc.2012.09.104","article-title":"Activation of transmembrane bile acid receptor TGR5 stimulates insulin secretion in pancreatic beta cells","volume":"427","author":"Kumar","year":"2012","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib41","doi-asserted-by":"crossref","first-page":"13689","DOI":"10.1038\/s41598-017-13102-y","article-title":"Gpbar1 agonism promotes a Pgc-1alpha-dependent browning of white adipose tissue and energy expenditure and reverses diet-induced steatohepatitis in mice","volume":"7","author":"Carino","year":"2017","journal-title":"Sci. Rep."},{"issue":"10","key":"10.1016\/j.phrs.2026.108320_bib42","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1172\/JCI21025","article-title":"Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c","volume":"113","author":"Watanabe","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"10","key":"10.1016\/j.phrs.2026.108320_bib43","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1007\/s11695-018-3297-6","article-title":"Roux-en-Y Gastric Bypass Surgery-Induced Weight Loss and Metabolic Improvements Are Similar in TGR5-Deficient and Wildtype Mice","volume":"28","author":"Hao","year":"2018","journal-title":"Obes. Surg."},{"issue":"10","key":"10.1016\/j.phrs.2026.108320_bib44","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1073\/pnas.0400046101","article-title":"Expression and activation of the farnesoid X receptor in the vasculature","volume":"101","author":"Bishop-Bailey","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/cvr\/cvm016","article-title":"FXR-mediated regulation of eNOS expression in vascular endothelial cells","volume":"77","author":"Li","year":"2008","journal-title":"Cardiovasc. Res."},{"issue":"5418","key":"10.1016\/j.phrs.2026.108320_bib46","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.phrs.2026.108320_bib47","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1136\/gut.14.7.513","article-title":"Postprandial concentrations of free and conjugated bile acids down the length of the normal human small intestine","volume":"14","author":"Northfield","year":"1973","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib48","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jhep.2012.08.002","article-title":"Bile acid transporters and regulatory nuclear receptors in the liver and beyond","volume":"58","author":"Halilbasic","year":"2013","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib49","first-page":"123","article-title":"Ursodeoxycholic acid alone or with chenodeoxycholic acid for dissolution of cholesterol gallstones: a randomized multicentre trial","volume":"15","author":"Petroni","year":"2001","journal-title":"Br. -Ital. Gall. Study Group. Aliment. Pharmacol. Ther."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib50","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1242\/dev.094805","article-title":"Sphingosine 1-phosphate signalling","volume":"141","author":"Mendelson","year":"2014","journal-title":"Development"},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib51","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.prp.2011.11.008","article-title":"LPS and TNF-alpha induce expression of sphingosine-1-phosphate receptor-2 in human microvascular endothelial cells","volume":"208","author":"Du","year":"2012","journal-title":"Pathol. Res. Pract."},{"issue":"6","key":"10.1016\/j.phrs.2026.108320_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.70351","article-title":"S1PR2 Mediates Smooth Muscle Cell Proliferation and Endothelial Cell Permeability via Akt\/mTOR and RhoA\/ROCK1 in Atherosclerosis","volume":"39","author":"Ouyang","year":"2025","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0317568","article-title":"Activation of S1PR2 on macrophages and the hepatocyte S1PR2\/RhoA\/ROCK1\/MLC2 pathway in vanishing bile duct syndrome","volume":"20","author":"Miyagawa-Hayashino","year":"2025","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib54","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hep.24681","article-title":"Conjugated bile acids activate the sphingosine-1-phosphate receptor 2 in primary rodent hepatocytes","volume":"55","author":"Studer","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.phrs.2026.108320_bib55","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ejphar.2016.02.056","article-title":"Sphingosine-1-phosphate receptor 2 mediates endothelial cells dysfunction by PI3K-Akt pathway under high glucose condition","volume":"776","author":"Liu","year":"2016","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib56","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1002\/hep.27592","article-title":"Conjugated bile acid-activated S1P receptor 2 is a key regulator of sphingosine kinase 2 and hepatic gene expression","volume":"61","author":"Nagahashi","year":"2015","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib57","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jphs.2016.05.010","article-title":"Cellular function and signaling pathways of vascular smooth muscle cells modulated by sphingosine 1-phosphate","volume":"132","author":"Machida","year":"2016","journal-title":"J. Pharmacol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib58","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/cvr\/cvm068","article-title":"FXR-mediated regulation of angiotensin type 2 receptor expression in vascular smooth muscle cells","volume":"77","author":"Zhang","year":"2008","journal-title":"Cardiovasc. Res."},{"issue":"6220","key":"10.1016\/j.phrs.2026.108320_bib59","doi-asserted-by":"crossref","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib60","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/j.1365-2125.2008.03194.x","article-title":"Contribution of the M3 muscarinic receptors to the vasodilator response to acetylcholine in the human forearm vascular bed","volume":"66","author":"Attina","year":"2008","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"23","key":"10.1016\/j.phrs.2026.108320_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222313153","article-title":"Differential Actions of Muscarinic Receptor Subtypes in Gastric, Pancreatic, and Colon Cancer","volume":"22","author":"Schledwitz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009689","article-title":"Bile acid-induced arrhythmia is mediated by muscarinic M2 receptors in neonatal rat cardiomyocytes","volume":"5","author":"Sheikh Abdul Kadir","year":"2010","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib63","doi-asserted-by":"crossref","first-page":"7110","DOI":"10.1038\/s41598-018-25569-4","article-title":"Bile acids and their respective conjugates elicit different responses in neonatal cardiomyocytes: role of Gi protein, muscarinic receptors and TGR5","volume":"8","author":"Ibrahim","year":"2018","journal-title":"Sci. Rep."},{"issue":"9","key":"10.1016\/j.phrs.2026.108320_bib64","doi-asserted-by":"crossref","first-page":"R969","DOI":"10.1152\/ajpregu.00322.2013","article-title":"Vitamin D and the heart","volume":"305","author":"Gardner","year":"2013","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.phrs.2026.108320_bib65","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jsbmb.2018.11.004","article-title":"Determinants of vitamin D receptor gene expression in visceral and subcutaneous adipose tissue in non-obese, obese, and morbidly obese subjects","volume":"187","author":"Yuzbashian","year":"2019","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"5571","key":"10.1016\/j.phrs.2026.108320_bib66","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.1070477","article-title":"Vitamin D receptor as an intestinal bile acid sensor","volume":"296","author":"Makishima","year":"2002","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib67","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.taap.2003.12.027","article-title":"PXR (NR1I2): splice variants in human tissues, including brain, and identification of neurosteroids and nicotine as PXR activators","volume":"199","author":"Lamba","year":"2004","journal-title":"Toxicol. Appl. Pharmacol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib68","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1093\/cvr\/cvr330","article-title":"Pregnane X receptor regulates drug metabolism and transport in the vasculature and protects from oxidative stress","volume":"93","author":"Swales","year":"2012","journal-title":"Cardiovasc. Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib69","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0022-2275(20)30141-3","article-title":"Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor","volume":"43","author":"Kliewer","year":"2002","journal-title":"J. Lipid Res."},{"issue":"8","key":"10.1016\/j.phrs.2026.108320_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19082307","article-title":"Beyond the Foam Cell: The Role of LXRs in Preventing Atherogenesis","volume":"19","author":"Rasheed","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.phrs.2026.108320_bib71","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1038\/ijo.2012.21","article-title":"Liver X receptors and fat cell metabolism","volume":"36","author":"Laurencikiene","year":"2012","journal-title":"Int. J. Obes. (Lond. )"},{"issue":"5","key":"10.1016\/j.phrs.2026.108320_bib72","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s11373-007-9160-8","article-title":"Modulation of liver X receptor signaling as novel therapy for prostate cancer","volume":"14","author":"Chuu","year":"2007","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.phrs.2026.108320_bib73","doi-asserted-by":"crossref","DOI":"10.1155\/2009\/501739","article-title":"Regulation of bile acid and cholesterol metabolism by PPARs","volume":"2009","author":"Li","year":"2009","journal-title":"PPAR Res."},{"key":"10.1016\/j.phrs.2026.108320_bib74","doi-asserted-by":"crossref","first-page":"43290","DOI":"10.1038\/srep43290","article-title":"Hyodeoxycholic acid derivatives as liver X receptor alpha and G-protein-coupled bile acid receptor agonists","volume":"7","author":"De Marino","year":"2017","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib75","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1210\/endo.137.1.8536636","article-title":"Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat","volume":"137","author":"Braissant","year":"1996","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib76","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPARalpha action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"issue":"11","key":"10.1016\/j.phrs.2026.108320_bib77","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1194\/jlr.M088419","article-title":"Extrahepatic PPARalpha modulates fatty acid oxidation and attenuates fasting-induced hepatosteatosis in mice","volume":"59","author":"Brocker","year":"2018","journal-title":"J. Lipid Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib78","doi-asserted-by":"crossref","first-page":"5451","DOI":"10.1038\/s41467-023-41061-8","article-title":"Hyodeoxycholic acid ameliorates nonalcoholic fatty liver disease by inhibiting RAN-mediated PPARalpha nucleus-cytoplasm shuttling","volume":"14","author":"Zhong","year":"2023","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib79","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1085\/jgp.20028537","article-title":"Natural bile acids and synthetic analogues modulate large conductance Ca2+-activated K+ (BKCa) channel activity in smooth muscle cells","volume":"119","author":"Dopico","year":"2002","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.phrs.2026.108320_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mce.2018.12.006","article-title":"Evidence of functional bile acid signaling pathways in adipocytes","volume":"483","author":"Schmid","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib81","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4049\/jimmunol.1700183","article-title":"The Bile Acid Receptor GPBAR1 Regulates the M1\/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis","volume":"199","author":"Biagioli","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.phrs.2026.108320_bib82","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.yjmcc.2020.10.014","article-title":"DCA-TGR5 signaling activation alleviates inflammatory response and improves cardiac function in myocardial infarction","volume":"151","author":"Wang","year":"2021","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.phrs.2026.108320_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101686","article-title":"Adipocyte-specific FXR-deficiency protects adipose tissue from oxidative stress and insulin resistance and improves glucose homeostasis","volume":"69","author":"Dehondt","year":"2023","journal-title":"Mol. Metab."},{"key":"10.1016\/j.phrs.2026.108320_bib84","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1065790","article-title":"Stimulation of the farnesoid X receptor promotes M2 macrophage polarization","volume":"14","author":"Jaroonwitchawan","year":"2023","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.phrs.2026.108320_bib85","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1002\/hep.27999","article-title":"Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis","volume":"62","author":"Singh","year":"2015","journal-title":"Hepatology"},{"issue":"2-3","key":"10.1016\/j.phrs.2026.108320_bib86","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0014-2999(02)02690-0","article-title":"Selective interaction of bile acids with muscarinic receptors: a case of molecular mimicry","volume":"457","author":"Raufman","year":"2002","journal-title":"Eur. J. Pharmacol."},{"issue":"7809","key":"10.1016\/j.phrs.2026.108320_bib87","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/s41586-020-2193-0","article-title":"Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells","volume":"581","author":"Campbell","year":"2020","journal-title":"Nature"},{"issue":"6602","key":"10.1016\/j.phrs.2026.108320_bib88","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/383728a0","article-title":"An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha","volume":"383","author":"Janowski","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.phrs.2026.108320_bib89","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.125.012674","article-title":"Cellular Interactions and Immunometabolic Mechanisms in Heart Failure With Preserved Ejection Fraction: From Molecular Mechanisms to Clinical Evidence","author":"Peikert","year":"2026","journal-title":"Circ. Heart Fail."},{"issue":"32","key":"10.1016\/j.phrs.2026.108320_bib90","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1093\/eurheartj\/ehaf368","article-title":"CardioMetabolic medicine: the advent of systems cardiology and the new cardiovascular generalist?","volume":"46","author":"Luscher","year":"2025","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib91","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1172\/JCI92035","article-title":"Inflammatory mechanisms linking obesity and metabolic disease","volume":"127","author":"Saltiel","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.phrs.2026.108320_bib92","doi-asserted-by":"crossref","DOI":"10.1111\/1755-5922.12462","article-title":"TGR5 activation induces cytoprotective changes in the heart and improves myocardial adaptability to physiologic, inotropic, and pressure-induced stress in mice","volume":"36","author":"Eblimit","year":"2018","journal-title":"Cardiovasc. Ther."},{"issue":"24","key":"10.1016\/j.phrs.2026.108320_bib93","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1093\/eurheartj\/ehs011","article-title":"Cardiomyocyte-expressed farnesoid-X-receptor is a novel apoptosis mediator and contributes to myocardial ischaemia\/reperfusion injury","volume":"34","author":"Pu","year":"2013","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib94","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.yexcr.2018.07.004","article-title":"Effects of farnesoid-X-receptor SUMOylation mutation on myocardial ischemia\/reperfusion injury in mice","volume":"371","author":"Gao","year":"2018","journal-title":"Exp. Cell. Res."},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib95","doi-asserted-by":"crossref","first-page":"137","DOI":"10.23736\/S0031-0808.20.03930-0","article-title":"Activation of FXR receptor reduces damage of ET-1 on H9C2 cardiomyocytes by activating AMPK signaling pathway","volume":"66","author":"Li","year":"2024","journal-title":"Panminerva Med."},{"key":"10.1016\/j.phrs.2026.108320_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108033","article-title":"Knockout of farnesoid X receptor aggravates process of diabetic cardiomyopathy","volume":"161","author":"Qiang","year":"2020","journal-title":"Diabetes Res. Clin. Pract."},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib97","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.numecd.2011.06.008","article-title":"FXR activation improves myocardial fatty acid metabolism in a rodent model of obesity-driven cardiotoxicity","volume":"23","author":"Mencarelli","year":"2013","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib98","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00592-020-01652-z","article-title":"Farnesoid X receptor (FXR) agonist ameliorates systemic insulin resistance, dysregulation of lipid metabolism, and alterations of various organs in a type 2 diabetic kidney animal model","volume":"58","author":"Han","year":"2021","journal-title":"Acta Diabetol."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib99","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00210-020-01962-7","article-title":"Chenodeoxycholic and deoxycholic acids induced positive inotropic and negative chronotropic effects on rat heart","volume":"394","author":"Gao","year":"2021","journal-title":"Naunyn Schmiede Arch. Pharmacol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108320_bib100","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1111\/j.1476-5381.2012.02117.x","article-title":"Regulation of apoptosis in HL-1 cardiomyocytes by phosphorylation of the receptor tyrosine kinase EphA2 and protection by lithocholic acid","volume":"167","author":"Jehle","year":"2012","journal-title":"Br. J. Pharmacol."},{"issue":"17","key":"10.1016\/j.phrs.2026.108320_bib101","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1161\/CIRCULATIONAHA.111.032680","article-title":"Cardiomyocyte-specific deletion of the vitamin D receptor gene results in cardiac hypertrophy","volume":"124","author":"Chen","year":"2011","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib102","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/s41598-018-19708-0","article-title":"Effects of vitamin D supplementation on inflammatory markers in heart failure: a systematic review and meta-analysis of randomized controlled trials","volume":"8","author":"Rodriguez","year":"2018","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.phrs.2026.108320_bib103","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/cbf.3303","article-title":"Ursodeoxycholic acid protects cardiomyocytes against cobalt chloride induced hypoxia by regulating transcriptional mediator of cells stress hypoxia inducible factor 1alpha and p53 protein","volume":"35","author":"Mohamed","year":"2017","journal-title":"Cell. Biochem. Funct."},{"issue":"7","key":"10.1016\/j.phrs.2026.108320_bib104","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1111\/jog.14765","article-title":"Fas, Caspase-8, and Caspase-9 pathway-mediated bile acid-induced fetal cardiomyocyte apoptosis in intrahepatic cholestasis pregnant rat models","volume":"47","author":"Song","year":"2021","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"5","key":"10.1016\/j.phrs.2026.108320_bib105","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1471-0528.2003.02273.x","article-title":"Dexamethasone and ursodeoxycholic acid protect against the arrhythmogenic effect of taurocholate in an in vitro study of rat cardiomyocytes","volume":"110","author":"Gorelik","year":"2003","journal-title":"BJOG"},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib106","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1002\/hep.24492","article-title":"A protective antiarrhythmic role of ursodeoxycholic acid in an in vitro rat model of the cholestatic fetal heart","volume":"54","author":"Miragoli","year":"2011","journal-title":"Hepatology"},{"issue":"1-3","key":"10.1016\/j.phrs.2026.108320_bib107","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pbiomolbio.2016.01.003","article-title":"The protective effect of ursodeoxycholic acid in an in vitro model of the human fetal heart occurs via targeting cardiac fibroblasts","volume":"120","author":"Schultz","year":"2016","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108320_bib108","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183167","article-title":"Ursodeoxycholic acid prevents ventricular conduction slowing and arrhythmia by restoring T-type calcium current in fetuses during cholestasis","volume":"12","author":"Adeyemi","year":"2017","journal-title":"PLoS. One"},{"issue":"10","key":"10.1016\/j.phrs.2026.108320_bib109","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1111\/liv.13394","article-title":"Bile acids and cardiovascular function in cirrhosis","volume":"37","author":"Voiosu","year":"2017","journal-title":"Liver Int."},{"issue":"6","key":"10.1016\/j.phrs.2026.108320_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/cells11061014","article-title":"Platelets, a Key Cell in Inflammation and Atherosclerosis Progression","volume":"11","author":"Huilcaman","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib111","doi-asserted-by":"crossref","DOI":"10.1080\/09537104.2024.2322733","article-title":"The bile acid receptor TGR5 inhibits platelet activation and thrombus formation","volume":"35","author":"Reusswig","year":"2024","journal-title":"Platelets"},{"issue":"12","key":"10.1016\/j.phrs.2026.108320_bib112","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1161\/ATVBAHA.116.308093","article-title":"Farnesoid X Receptor and Its Ligands Inhibit the Function of Platelets","volume":"36","author":"Moraes","year":"2016","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"9","key":"10.1016\/j.phrs.2026.108320_bib113","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/s41574-019-0230-6","article-title":"The endocrine function of adipose tissues in health and cardiometabolic disease","volume":"15","author":"Scheja","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib114","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41467-017-02068-0","article-title":"TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue","volume":"9","author":"Velazquez-Villegas","year":"2018","journal-title":"Nat. Commun."},{"issue":"9","key":"10.1016\/j.phrs.2026.108320_bib116","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1194\/jlr.M094508","article-title":"FXR overexpression alters adipose tissue architecture in mice and limits its storage capacity leading to metabolic derangements","volume":"60","author":"van Zutphen","year":"2019","journal-title":"J. Lipid Res."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2025.100754","article-title":"Deleting adipose FXR exacerbates metabolic defects and induces endocannabinoid lipid, 2-oleoyl glycerol, in obesity","volume":"66","author":"Zhou","year":"2025","journal-title":"J. Lipid Res."},{"issue":"11","key":"10.1016\/j.phrs.2026.108320_bib118","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.tem.2023.08.002","article-title":"The emerging role of bile acids in white adipose tissue","volume":"34","author":"Schmid","year":"2023","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib119","article-title":"Role of bile acid receptor FXR in development and function of brown adipose tissue","volume":"1868","author":"Yang","year":"2023","journal-title":"Biochim. Biophys. Acta Mol. Cell. Biol. Lipids"},{"issue":"11","key":"10.1016\/j.phrs.2026.108320_bib121","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.2337\/db10-0412","article-title":"DsbA-L alleviates endoplasmic reticulum stress-induced adiponectin downregulation","volume":"59","author":"Zhou","year":"2010","journal-title":"Diabetes"},{"issue":"21","key":"10.1016\/j.phrs.2026.108320_bib122","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21218168","article-title":"Downregulation of CTRP-3 by Weight Loss In Vivo and by Bile Acids and Incretins in Adipocytes In Vitro","volume":"21","author":"Schmid","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.phrs.2026.108320_bib123","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.mce.2015.07.012","article-title":"Chenodeoxycholic acid, an endogenous FXR ligand alters adipokines and reverses insulin resistance","volume":"414","author":"Shihabudeen","year":"2015","journal-title":"Mol. Cell. Endocrinol."},{"issue":"7640","key":"10.1016\/j.phrs.2026.108320_bib124","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib125","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib126","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1111\/ajt.16327","article-title":"TGR5\/Cathepsin E signaling regulates macrophage innate immune activation in liver ischemia and reperfusion injury","volume":"21","author":"Zhou","year":"2021","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib127","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/imm.12045","article-title":"TGR5 signalling inhibits the production of pro-inflammatory cytokines by in vitro differentiated inflammatory and intestinal macrophages in Crohn's disease","volume":"139","author":"Yoneno","year":"2013","journal-title":"Immunology"},{"key":"10.1016\/j.phrs.2026.108320_bib128","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.677738","article-title":"Inflammatory-Dependent Bidirectional Effect of Bile Acids on NLRP3 Inflammasome and Its Role in Ameliorating CPT-11-Induced Colitis","volume":"13","author":"Liao","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"7785","key":"10.1016\/j.phrs.2026.108320_bib130","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41586-019-1785-z","article-title":"Bile acid metabolites control T(H)17 and T(reg) cell differentiation","volume":"576","author":"Hang","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib131","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1172\/JCI88884","article-title":"Therapeutic approaches targeting inflammation for diabetes and associated cardiovascular risk","volume":"127","author":"Goldfine","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib132","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.metabol.2015.10.021","article-title":"The bile acid TUDCA increases glucose-induced insulin secretion via the cAMP\/PKA pathway in pancreatic beta cells","volume":"65","author":"Vettorazzi","year":"2016","journal-title":"Metabolism"},{"issue":"211","key":"10.1016\/j.phrs.2026.108320_bib133","doi-asserted-by":"crossref","first-page":"211ra156","DOI":"10.1126\/scitranslmed.3006534","article-title":"Restoration of the unfolded protein response in pancreatic beta cells protects mice against type 1 diabetes","volume":"5","author":"Engin","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"6","key":"10.1016\/j.phrs.2026.108320_bib134","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/db11-0815","article-title":"Bile acids acutely stimulate insulin secretion of mouse beta-cells via farnesoid X receptor activation and K(ATP) channel inhibition","volume":"61","author":"Dufer","year":"2012","journal-title":"Diabetes"},{"issue":"13","key":"10.1016\/j.phrs.2026.108320_bib135","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1016\/j.febslet.2010.04.068","article-title":"The nuclear receptor FXR is expressed in pancreatic beta-cells and protects human islets from lipotoxicity","volume":"584","author":"Popescu","year":"2010","journal-title":"FEBS Lett."},{"key":"10.1016\/j.phrs.2026.108320_bib136","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fphys.2014.00420","article-title":"Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac\/PLC-epsilon pathway and modulated by endogenous H2S","volume":"5","author":"Bala","year":"2014","journal-title":"Front. Physiol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib137","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/emm.2000.18","article-title":"The mechanism of phospholipase C-gamma1 regulation","volume":"32","author":"Kim","year":"2000","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib138","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S0022-2275(20)43096-2","article-title":"Mechanisms for the intestinal absorption of bile acids","volume":"9","author":"Dietschy","year":"1968","journal-title":"J. Lipid Res."},{"issue":"9","key":"10.1016\/j.phrs.2026.108320_bib139","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/j.bbalip.2010.06.002","article-title":"Getting the mOST from OST: Role of organic solute transporter, OSTalpha-OSTbeta, in bile acid and steroid metabolism","volume":"1801","author":"Dawson","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib140","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell. Metab."},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib141","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1476-5381.2011.01561.x","article-title":"Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion","volume":"165","author":"Parker","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2026.108320_bib142","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/srep00430","article-title":"TGR5 potentiates GLP-1 secretion in response to anionic exchange resins","volume":"2","author":"Harach","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108320_bib143","doi-asserted-by":"crossref","first-page":"7629","DOI":"10.1038\/ncomms8629","article-title":"Farnesoid X receptor inhibits glucagon-like peptide-1 production by enteroendocrine L cells","volume":"6","author":"Trabelsi","year":"2015","journal-title":"Nat. Commun."},{"issue":"13","key":"10.1016\/j.phrs.2026.108320_bib144","doi-asserted-by":"crossref","first-page":"6626","DOI":"10.1074\/jbc.M115.699504","article-title":"Activation of Transmembrane Bile Acid Receptor TGR5 Modulates Pancreatic Islet alpha Cells to Promote Glucose Homeostasis","volume":"291","author":"Kumar","year":"2016","journal-title":"J. Biol. Chem."},{"issue":"44","key":"10.1016\/j.phrs.2026.108320_bib145","doi-asserted-by":"crossref","first-page":"45685","DOI":"10.1074\/jbc.M404255200","article-title":"Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4","volume":"279","author":"Hirokane","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.phrs.2026.108320_bib146","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI0214505","article-title":"Bile acid-activated nuclear receptor FXR suppresses apolipoprotein A-I transcription via a negative FXR response element","volume":"109","author":"Claudel","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.phrs.2026.108320_bib147","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1074\/jbc.M109.083899","article-title":"Identification of novel pathways that control farnesoid X receptor-mediated hypocholesterolemia","volume":"285","author":"Zhang","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.phrs.2026.108320_bib148","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1194\/jlr.C200014-JLR200","article-title":"Identification of PLTP as an LXR target gene and apoE as an FXR target gene reveals overlapping targets for the two nuclear receptors","volume":"43","author":"Mak","year":"2002","journal-title":"J. Lipid Res."},{"issue":"5","key":"10.1016\/j.phrs.2026.108320_bib149","first-page":"1927","article-title":"Activation of FXR by obeticholic acid induces hepatic gene expression of SR-BI through a novel mechanism of transcriptional synergy with the nuclear receptor LXR","volume":"43","author":"Dong","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"6","key":"10.1016\/j.phrs.2026.108320_bib150","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.febslet.2008.02.038","article-title":"Activation of the farnesoid X receptor represses PCSK9 expression in human hepatocytes","volume":"582","author":"Langhi","year":"2008","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.phrs.2026.108320_bib151","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/joim.12594","article-title":"Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III","volume":"281","author":"Ghosh Laskar","year":"2017","journal-title":"J. Intern. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib152","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s13020-025-01178-y","article-title":"Regulatory mechanisms of hepatocyte PCSK9 expression: translating mechanistic insights into potential nutraceuticals","volume":"20","author":"Park","year":"2025","journal-title":"Chin. Med."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib153","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s12072-010-9202-6","article-title":"Effects of nuclear receptor FXR on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease","volume":"4","author":"Yang","year":"2010","journal-title":"Hepatol. Int."},{"issue":"5 1","key":"10.1016\/j.phrs.2026.108320_bib155","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1538-7836.2007.02517.x","article-title":"Platelets, inflammation and atherosclerosis","author":"Lindemann","year":"2007","journal-title":"J. Thromb. Haemost."},{"issue":"32","key":"10.1016\/j.phrs.2026.108320_bib156","article-title":"Mechanism of Bile Acid in Regulating Platelet Function and Thrombotic Diseases","volume":"11","author":"Zhou","year":"2024","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib157","doi-asserted-by":"crossref","first-page":"324","DOI":"10.2337\/db18-0315","article-title":"TGR5 Activation Promotes Stimulus-Secretion Coupling of Pancreatic beta-Cells via a PKA-Dependent Pathway","volume":"68","author":"Maczewsky","year":"2019","journal-title":"Diabetes"},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib158","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","article-title":"Bile acids and the gut microbiota: metabolic interactions and impacts on disease","volume":"21","author":"Collins","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib159","doi-asserted-by":"crossref","first-page":"22661","DOI":"10.1038\/s41598-021-02144-y","article-title":"Circulating bile acids concentration is predictive of coronary artery disease in human","volume":"11","author":"Chong Nguyen","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.phrs.2026.108320_bib160","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.atherosclerosis.2019.11.026","article-title":"Fasting serum total bile acid level is associated with coronary artery disease, myocardial infarction and severity of coronary lesions","volume":"292","author":"Li","year":"2020","journal-title":"Atherosclerosis"},{"issue":"5","key":"10.1016\/j.phrs.2026.108320_bib161","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.ajcnut.2025.09.026","article-title":"Associations between serum bile acid profile and mortality in patients with coronary artery disease: a cohort study","volume":"122","author":"Zeng","year":"2025","journal-title":"Am. J. Clin. Nutr."},{"issue":"18","key":"10.1016\/j.phrs.2026.108320_bib162","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26188764","article-title":"Reduced Systemic Levels of Bile Acids in Individuals with Coronary Artery Disease: Insights from a Systematic Review","volume":"26","author":"Lopez Espinosa","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib163","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12944-024-02184-z","article-title":"Sex differences in lipidomic and bile acid plasma profiles in patients with and without coronary artery disease","volume":"23","author":"Bay","year":"2024","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.phrs.2026.108320_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.754006","article-title":"Myocardial Infarction and Coronary Artery Disease in Menopausal Women With Type 2 Diabetes Mellitus Negatively Correlate With Total Serum Bile Acids","volume":"12","author":"Feng","year":"2021","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib165","first-page":"261","article-title":"The Role of Bile Acids in Cardiovascular Diseases: from Mechanisms to Clinical Implications","volume":"14","author":"Zhang","year":"2023","journal-title":"Aging Dis."},{"issue":"4 Pt B","key":"10.1016\/j.phrs.2026.108320_bib166","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.bbadis.2017.12.039","article-title":"Heart and bile acids - Clinical consequences of altered bile acid metabolism","volume":"1864","author":"Vasavan","year":"2018","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib167","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1007\/s00125-011-2382-3","article-title":"Effect of bile acid sequestrants on glucose metabolism, hepatic de novo lipogenesis, and cholesterol and bile acid kinetics in type 2 diabetes: a randomised controlled study","volume":"55","author":"Beysen","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.phrs.2026.108320_bib168","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.ijcard.2016.10.011","article-title":"The effects of bile acid sequestrants on lipid profile and blood glucose concentrations: A systematic review and meta-analysis of randomized controlled trials","volume":"227","author":"Mazidi","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib169","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz025","article-title":"Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology","volume":"105","author":"Bronden","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.atherosclerosis.2013.02.021","article-title":"Bile acid sequestration normalizes plasma cholesterol and reduces atherosclerosis in hypercholesterolemic mice. No additional effect of physical activity","volume":"228","author":"Meissner","year":"2013","journal-title":"Atherosclerosis"},{"issue":"6","key":"10.1016\/j.phrs.2026.108320_bib171","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","article-title":"TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading","volume":"14","author":"Pols","year":"2011","journal-title":"Cell. Metab."},{"issue":"9","key":"10.1016\/j.phrs.2026.108320_bib172","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142865","article-title":"Suppressing the intestinal farnesoid X receptor\/sphingomyelin phosphodiesterase 3 axis decreases atherosclerosis","volume":"131","author":"Wu","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"22","key":"10.1016\/j.phrs.2026.108320_bib173","doi-asserted-by":"crossref","first-page":"8732","DOI":"10.1074\/jbc.RA119.008360","article-title":"Phosphorylation of hepatic farnesoid X receptor by FGF19 signaling-activated Src maintains cholesterol levels and protects from atherosclerosis","volume":"294","author":"Byun","year":"2019","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2026.108320_bib174","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13098-017-0299-9","article-title":"Bile acids at the cross-roads of gut microbiome-host cardiometabolic interactions","volume":"9","author":"Ryan","year":"2017","journal-title":"Diabetol. Metab. Syndr."},{"issue":"7","key":"10.1016\/j.phrs.2026.108320_bib175","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019820","article-title":"Glycoursodeoxycholic Acid Ameliorates Atherosclerosis and Alters Gut Microbiota in Apolipoprotein E-Deficient Mice","volume":"10","author":"Huang","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib176","doi-asserted-by":"crossref","DOI":"10.3390\/biom8040159","article-title":"Overview of Bile Acids Signaling and Perspective on the Signal of Ursodeoxycholic Acid, the Most Hydrophilic Bile Acid, in the Heart","volume":"8","author":"Hanafi","year":"2018","journal-title":"Biomolecules"},{"issue":"10","key":"10.1016\/j.phrs.2026.108320_bib177","doi-asserted-by":"crossref","first-page":"851","DOI":"10.14348\/molcells.2015.0094","article-title":"Ursodeoxycholic Acid (UDCA) Exerts Anti-Atherogenic Effects by Inhibiting Endoplasmic Reticulum (ER) Stress Induced by Disturbed Flow","volume":"38","author":"Chung","year":"2015","journal-title":"Mol. Cells"},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib178","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s12265-021-10164-2","article-title":"Roles and Mechanisms of TGR5 in the Modulation of CD4(+) T Cell Functions in Myocardial Infarction","volume":"15","author":"Wang","year":"2022","journal-title":"J. Cardiovasc. Transl. Res."},{"issue":"10","key":"10.1016\/j.phrs.2026.108320_bib179","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/cvr\/cvy093","article-title":"Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction","volume":"114","author":"Xia","year":"2018","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib180","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3892\/mmr.2017.6643","article-title":"Farnesoid X receptor deletion improves cardiac function, structure and remodeling following myocardial infarction in mice","volume":"16","author":"Gao","year":"2017","journal-title":"Mol. Med. Rep."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib181","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41574-024-01067-8","article-title":"Bile acid metabolism in type 2 diabetes mellitus","volume":"21","author":"Cadena Sandoval","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib182","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s13098-023-01207-6","article-title":"Research progress on the relationship between bile acid metabolism and type 2 diabetes mellitus","volume":"15","author":"Hou","year":"2023","journal-title":"Diabetol. Metab. Syndr."},{"issue":"6","key":"10.1016\/j.phrs.2026.108320_bib183","doi-asserted-by":"crossref","DOI":"10.3390\/metabo15060401","article-title":"Bile Acids and Type 2 Diabetes: Roles in Glucose Homeostasis and Therapeutic Opportunities","volume":"15","author":"Lin","year":"2025","journal-title":"Metabolites"},{"issue":"11","key":"10.1016\/j.phrs.2026.108320_bib184","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1016\/j.ekir.2024.08.002","article-title":"Role of Bile Acid Receptors in the Development and Function of Diabetic Nephropathy","volume":"9","author":"Fang","year":"2024","journal-title":"Kidney Int. Rep."},{"issue":"6","key":"10.1016\/j.phrs.2026.108320_bib185","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/s42255-024-01036-5","article-title":"Inhibition of fatty acid uptake by TGR5 prevents diabetic cardiomyopathy","volume":"6","author":"Wang","year":"2024","journal-title":"Nat. Metab."},{"issue":"6","key":"10.1016\/j.phrs.2026.108320_bib186","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1038\/s42255-024-01032-9","article-title":"Bile acids for diabetic cardiomyopathy","volume":"6","author":"Weissman","year":"2024","journal-title":"Nat. Metab."},{"key":"10.1016\/j.phrs.2026.108320_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.05.022","article-title":"Obeticholic acid protects against diabetic cardiomyopathy by activation of FXR\/Nrf2 signaling in db\/db mice","volume":"858","author":"Wu","year":"2019","journal-title":"Eur. J. Pharmacol."},{"issue":"1-2","key":"10.1016\/j.phrs.2026.108320_bib188","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1582-4934.2009.00997.x","article-title":"FXR an emerging therapeutic target for the treatment of atherosclerosis","volume":"14","author":"Mencarelli","year":"2010","journal-title":"J. Cell. Mol. Med."},{"issue":"9","key":"10.1016\/j.phrs.2026.108320_bib189","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108270","article-title":"Dual activation of the bile acid nuclear receptor FXR and G-protein-coupled receptor TGR5 protects mice against atherosclerosis","volume":"9","author":"Miyazaki-Anzai","year":"2014","journal-title":"PLoS. One"},{"issue":"10","key":"10.1016\/j.phrs.2026.108320_bib190","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.1073\/pnas.0509592103","article-title":"Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor","volume":"103","author":"Inagaki","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib191","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.molmed.2021.10.005","article-title":"Linking liver metabolic and vascular disease via bile acid signaling","volume":"28","author":"Fiorucci","year":"2022","journal-title":"Trends Mol. Med."},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib192","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","article-title":"Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist","volume":"17","author":"Sayin","year":"2013","journal-title":"Cell. Metab."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib193","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1136\/gut.39.4.587","article-title":"Role of the gut in the pathophysiology of extrahepatic biliary obstruction","volume":"39","author":"Clements","year":"1996","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.phrs.2026.108320_bib194","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1097\/01.CCM.0000284586.84952.FB","article-title":"Conjugated primary bile salts reduce permeability of endotoxin through intestinal epithelial cells and synergize with phosphatidylcholine in suppression of inflammatory cytokine production","volume":"35","author":"Parlesak","year":"2007","journal-title":"Crit. Care Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib195","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1136\/gutjnl-2015-310283","article-title":"Microbiota-induced obesity requires farnesoid X receptor","volume":"66","author":"Parseus","year":"2017","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib196","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.chom.2008.02.015","article-title":"Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome","volume":"3","author":"Turnbaugh","year":"2008","journal-title":"Cell. Host Microbe"},{"issue":"10","key":"10.1016\/j.phrs.2026.108320_bib197","doi-asserted-by":"crossref","DOI":"10.3390\/nu12102982","article-title":"Gut Microbiota in Hypertension and Atherosclerosis: A Review","volume":"12","author":"Verhaar","year":"2020","journal-title":"Nutrients"},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib198","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1111\/jcmm.14195","article-title":"The role of intestinal microbiota in cardiovascular disease","volume":"23","author":"Jin","year":"2019","journal-title":"J. Cell. Mol. Med."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib199","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/s41569-018-0108-7","article-title":"Dietary metabolism, the gut microbiome, and heart failure","volume":"16","author":"Tang","year":"2019","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.phrs.2026.108320_bib200","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev-med-060513-093205","article-title":"The gut microbial endocrine organ: bacterially derived signals driving cardiometabolic diseases","volume":"66","author":"Brown","year":"2015","journal-title":"Annu. Rev. Med."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib201","doi-asserted-by":"crossref","first-page":"8664","DOI":"10.1038\/s41598-022-12720-5","article-title":"Effects of acute administration of trimethylamine N-oxide on endothelial function: a translational study","volume":"12","author":"Jomard","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.phrs.2026.108320_bib202","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1080\/1040841X.2023.2262020","article-title":"Bile acid and its bidirectional interactions with gut microbiota: a review","volume":"50","author":"He","year":"2024","journal-title":"Crit. Rev. Microbiol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib203","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jhep.2024.09.032","article-title":"Bile acid metabolism and signalling in liver disease","volume":"82","author":"Fuchs","year":"2025","journal-title":"J. Hepatol."},{"issue":"6","key":"10.1016\/j.phrs.2026.108320_bib204","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1124\/pharmrev.124.000978","article-title":"Bile Acid Signaling in Metabolic and Inflammatory Diseases and Drug Development","volume":"76","author":"Li","year":"2024","journal-title":"Pharmacol. Rev."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22031397","article-title":"Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver-Gut Axis","volume":"22","author":"Gruner","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"48","key":"10.1016\/j.phrs.2026.108320_bib206","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.3748\/wjg.v28.i48.6846","article-title":"Bile acids and microbes in metabolic disease","volume":"28","author":"Sah","year":"2022","journal-title":"World J. Gastroenterol."},{"issue":"14","key":"10.1016\/j.phrs.2026.108320_bib207","doi-asserted-by":"crossref","DOI":"10.3390\/nu17142347","article-title":"Dyslipidemia in Anorexia Nervosa Is Associated with Decreased Plasma Tauroursodeoxycholic Acid and a Specific Fatty Acid Pattern","volume":"17","author":"Zak","year":"2025","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib208","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2024.2357177","article-title":"From gut microbiota to brain: implications on binge eating disorders","volume":"16","author":"Guo","year":"2024","journal-title":"Gut Microbes"},{"issue":"5","key":"10.1016\/j.phrs.2026.108320_bib209","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41564-023-01355-5","article-title":"The gut microbiota contributes to the pathogenesis of anorexia nervosa in humans and mice","volume":"8","author":"Fan","year":"2023","journal-title":"Nat. Microbiol."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib210","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1159\/000371670","article-title":"Bile Acids as Hormones: The FXR-FGF15\/19 Pathway","volume":"33","author":"Kliewer","year":"2015","journal-title":"Dig. Dis."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib211","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1038\/s41467-018-04697-5","article-title":"Postprandial FGF19-induced phosphorylation by Src is critical for FXR function in bile acid homeostasis","volume":"9","author":"Byun","year":"2018","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.phrs.2026.108320_bib212","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","article-title":"FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption","volume":"33","author":"Clifford","year":"2021","journal-title":"Cell. Metab."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib213","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S1097-2765(03)00104-7","article-title":"A chemical, genetic, and structural analysis of the nuclear bile acid receptor FXR","volume":"11","author":"Downes","year":"2003","journal-title":"Mol. Cell."},{"issue":"19","key":"10.1016\/j.phrs.2026.108320_bib214","doi-asserted-by":"crossref","first-page":"13452","DOI":"10.1021\/acs.jmedchem.2c01394","article-title":"Discovery of Betulinic Acid Derivatives as Potent Intestinal Farnesoid X Receptor Antagonists to Ameliorate Nonalcoholic Steatohepatitis","volume":"65","author":"Zhang","year":"2022","journal-title":"J. Med. Chem."},{"issue":"8","key":"10.1016\/j.phrs.2026.108320_bib215","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/ijo.2016.46","article-title":"Influence of Roux-en-Y gastric bypass on plasma bile acid profiles: a comparative study between rats, pigs and humans","volume":"40","author":"Spinelli","year":"2016","journal-title":"Int. J. Obes. (Lond. )"},{"issue":"24","key":"10.1016\/j.phrs.2026.108320_bib216","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1021\/jm901390p","article-title":"Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity","volume":"52","author":"Pellicciari","year":"2009","journal-title":"J. Med. Chem."},{"issue":"11","key":"10.1016\/j.phrs.2026.108320_bib217","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0141082","article-title":"Reversal of Endothelial Dysfunction by GPBAR1 Agonism in Portal Hypertension Involves a AKT\/FOXOA1 Dependent Regulation of H2S Generation and Endothelin-1","volume":"10","author":"Renga","year":"2015","journal-title":"PLoS. One"},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib218","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/cpdd.34","article-title":"Safety, Pharmacokinetics, and Pharmacodynamic Effects of a Selective TGR5 Agonist, SB-756050, in Type 2 Diabetes","volume":"2","author":"Hodge","year":"2013","journal-title":"Clin. Pharmacol. Drug. Dev."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib219","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.bbrc.2007.06.130","article-title":"Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea","volume":"362","author":"Sato","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib220","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1021\/jm900872z","article-title":"Structure-activity relationship study of betulinic acid, a novel and selective TGR5 agonist, and its synthetic derivatives: potential impact in diabetes","volume":"53","author":"Genet","year":"2010","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.phrs.2026.108320_bib221","doi-asserted-by":"crossref","DOI":"10.3390\/ijms27041947","article-title":"Discovery of Obacunone as a TGR5 Agonist from Rhizoma coptidis: Affinity Screening, Functional Verification and Transcriptional Analysis","volume":"27","author":"Fu","year":"2026","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib222","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bbrc.2011.06.055","article-title":"Anti-obesity and anti-hyperglycemic effects of the dietary Citrus limonoid nomilin in mice fed a high-fat diet","volume":"410","author":"Ono","year":"2011","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2026.108320_bib223","doi-asserted-by":"crossref","first-page":"28676","DOI":"10.1038\/srep28676","article-title":"Intestinally-targeted TGR5 agonists equipped with quaternary ammonium have an improved hypoglycemic effect and reduced gallbladder filling effect","volume":"6","author":"Cao","year":"2016","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.phrs.2026.108320_bib224","doi-asserted-by":"crossref","first-page":"G412","DOI":"10.1152\/ajpgi.00300.2018","article-title":"Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice","volume":"316","author":"Finn","year":"2019","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib225","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41589-020-0604-z","article-title":"Bariatric surgery reveals a gut-restricted TGR5 agonist with anti-diabetic effects","volume":"17","author":"Chaudhari","year":"2021","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.phrs.2026.108320_bib226","doi-asserted-by":"crossref","first-page":"42801","DOI":"10.1038\/srep42801","article-title":"BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis","volume":"7","author":"Carino","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib227","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/JOE-17-0557","article-title":"INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function","volume":"238","author":"Comeglio","year":"2018","journal-title":"J. Endocrinol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108320_bib228","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1002\/ptr.7770","article-title":"Deoxyschizandrin ameliorates obesity and non-alcoholic fatty liver disease: Involvement of dual Farnesyl X receptor\/G protein-coupled bile acid receptor 1 activation and leptin sensitization","volume":"37","author":"Gu","year":"2023","journal-title":"Phytother. Res."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib229","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/liv.15767","article-title":"FXR agonists INT-787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet-induced ob\/ob mouse model of NASH","volume":"44","author":"Di Pasqua","year":"2024","journal-title":"Liver Int."},{"issue":"5","key":"10.1016\/j.phrs.2026.108320_bib230","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1053\/j.gastro.2010.07.052","article-title":"Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis","volume":"139","author":"Rao","year":"2010","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib231","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/hep.31205","article-title":"Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial","volume":"72","author":"Patel","year":"2020","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.phrs.2026.108320_bib232","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/s41591-022-02200-8","article-title":"Tropifexor for nonalcoholic steatohepatitis: an adaptive, randomized, placebo-controlled phase 2a\/b trial","volume":"29","author":"Sanyal","year":"2023","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.phrs.2026.108320_bib233","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.1021\/acs.jmedchem.9b01621","article-title":"Nidufexor (LMB763), a Novel FXR Modulator for the Treatment of Nonalcoholic Steatohepatitis","volume":"63","author":"Chianelli","year":"2020","journal-title":"J. Med. Chem."},{"issue":"1","key":"10.1016\/j.phrs.2026.108320_bib234","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jhep.2021.01.047","article-title":"A structurally optimized FXR agonist, MET409, reduced liver fat content over 12 weeks in patients with non-alcoholic steatohepatitis","volume":"75","author":"Harrison","year":"2021","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.phrs.2026.108320_bib235","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1111\/liv.14490","article-title":"A novel non-bile acid FXR agonist EDP-305 potently suppresses liver injury and fibrosis without worsening of ductular reaction","volume":"40","author":"An","year":"2020","journal-title":"Liver Int."},{"issue":"7","key":"10.1016\/j.phrs.2026.108320_bib236","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1038\/s41591-025-03722-7","article-title":"TERN-501 monotherapy and combination therapy with TERN-101 in metabolic dysfunction-associated steatohepatitis: the randomized phase 2a DUET trial","volume":"31","author":"Noureddin","year":"2025","journal-title":"Nat. Med."},{"issue":"39","key":"10.1016\/j.phrs.2026.108320_bib237","doi-asserted-by":"crossref","first-page":"14430","DOI":"10.3748\/wjg.v20.i39.14430","article-title":"FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation","volume":"20","author":"Yao","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.phrs.2026.108320_bib238","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2026.178910","article-title":"Intestinal-restricted farnesoid X receptor agonist Fex3 alleviates cholestatic liver injury via FGF15-CYP7A1 axis","volume":"1025","author":"Song","year":"2026","journal-title":"Eur. J. Pharmacol."},{"issue":"12","key":"10.1016\/j.phrs.2026.108320_bib239","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1002\/hep4.2099","article-title":"Glycine-beta-muricholic acid antagonizes the intestinal farnesoid X receptor-ceramide axis and ameliorates NASH in mice","volume":"6","author":"Jiang","year":"2022","journal-title":"Hepatol. Commun."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826002355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661826002355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:05:50Z","timestamp":1785906350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661826002355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":235,"alternative-id":["S1043661826002355"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108320","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bile acids: New regulators of the cardiometabolic crosstalk","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2026.108320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108320"}}